This commentary points out, "But as the FDA frets about the accuracy of 23andMe’s tests, it is missing their true function, and consequently the agency has no c

This commentary points out, "But as the FDA frets about the accuracy of 23andMe’s tests, it is missing their true function, and consequently the agency has no clue about the real dangers they pose. The Personal Genome Service isn’t primarily intended to be a medical device. It is a mechanism meant to be a front end for a massive information-gathering operation against an unwitting public." Yes. That was reported in a Fast Company magazine profile of 23andMe[1] submitted here to HN 44 days ago, with a lot of discussion.[2] The basic problem that 23andMe faces is a business model that by its own acknowledgement really doesn't provide much benefit to the consumers who are paying to have their DNA SNP-sequenced and their personal health history data collected for 23andMe's use. [1] http://www.fastcompany.com/3018598/for-99-this-ceo-can-tell-you-what-might-kill-you-inside-23andme-founder-anne-wojcickis-dna-r http://www.fastcompany.com/3018598/for-99-this-ceo-can-tell-... [2] https://news.ycombinator.com/item?id=6549600 https://news.ycombinator.com/item?id=6549600